CWM
ARDS

Cornerstone Wealth Management’s Aridis Pharmaceuticals Inc. Common Stock ARDS Stock Holding History

Cornerstone Wealth Management’s Portfolio ARDS Stock Details ARDS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-20,000
Closed -$4.4K – 556
2023
Q2 		$4.4K Buy
+20,000
New +$4.61K ﹤0.01% 502

Other funds holding ARDS

WA
Wealth Architects Mountain View, California $1.27B AUM 36.93% 1-Year Est. Return

Cornerstone Wealth Management's ARDS Position: Q3 2023 in Review

Cornerstone Wealth Management sold out of Aridis Pharmaceuticals Inc. Common Stock (ARDS) in Q3 2023, closing a stake of 20,000 shares — an estimated $4.4K sold.

Cornerstone Wealth Management first reported a position in ARDS in Q2 2023 and held it in 1 quarter. The position peaked at $4.4K in Q2 2023. 1 fund tracked by Wall St. Rank holds ARDS as of Q3 2023.

  • Cornerstone Wealth Management reported no remaining Aridis Pharmaceuticals Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Cornerstone Wealth Management sold 20,000 Aridis Pharmaceuticals Inc. Common Stock shares in Q3 2023, an estimated $4.4K.
  • Cornerstone Wealth Management first reported a position in Aridis Pharmaceuticals Inc. Common Stock in Q2 2023 and held it in 1 quarter.
  • Cornerstone Wealth Management's Aridis Pharmaceuticals Inc. Common Stock position peaked at $4.4K in Q2 2023.
  • 1 fund tracked by Wall St. Rank held Aridis Pharmaceuticals Inc. Common Stock as of Q3 2023.

Based on Cornerstone Wealth Management's 13F filing for Q3 2023, filed 7 Nov 2023.